An Overview of Immuno-Oncology

Course overview

This case based online course will provide an overview of immuno-oncology addressing: introduction to immune biomarkers, checkpoints, pathways (such as PD-1/PD-L1, PD-L2, and CTLA4), and their roles in cancer treatment; the current scope of immune-based cancer therapy and why it is important; how immuno-oncology affects the field of pathology, and why oncologists and patients are asking for immuno-oncology tests; an overview of currently available immuno-oncology therapies; and current efforts to identify other potential biomarkers of response to cancer immunotherapies, such as tumor mutational burden, microsatellite instability, and tumor-infiltrating lymphocytes. The activity offers 1.0 CME, CMLE, or SAMs CME credit.